Literature DB >> 15486048

Coimmunoprecipitation of UDP-glucuronosyltransferase isoforms and cytochrome P450 3A4.

Jacqueline J Fremont1, Regina W Wang, Christopher D King.   

Abstract

Coimmunoprecipitation was used to investigate protein-protein interactions between several UDP-glucuronosyltransferase (UGT) isoforms and cytochrome P450 3A4. Solubilized human liver microsomes were incubated with specific antibodies to UGT2B7, UGT1A6, UGT1A1, and CYP3A4, and the immunoprecipitates were run on SDS-polyacrylamide gel electrophoresis. Western blots showed that UGT2B7, UGT1A6, UGT1A1, and CYP3A4 were successfully immunoprecipitated with the specific antibodies for each enzyme. Upon immunoprecipitating UGT2B7, the corresponding immunoblot showed that UGT1A6, UGT1A1, and CYP3A4 were immunoprecipitated. Similar studies found that different UGT isoforms or CYP3A4 immunoprecipitated along with the original immunoprecipitating enzyme. These data suggest that UGT isoforms may form complexes (dimers, tetramers, etc.) with each other in the endoplasmic reticulum and nuclear envelope. In addition, the UGT isoforms tested here may have interacted with CYP3A4 in the endoplasmic reticulum, suggesting that these enzymes may cooperate in the excretion of compounds in a multistep metabolic process.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15486048     DOI: 10.1124/mol.104.006361

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Altered CYP2C9 activity following modulation of CYP3A4 levels in human hepatocytes: an example of protein-protein interactions.

Authors:  Diane Ramsden; Donald J Tweedie; Tom S Chan; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2014-08-25       Impact factor: 3.922

2.  Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes.

Authors:  Camille M Konopnicki; Leslie J Dickmann; Jeffrey M Tracy; Robert H Tukey; Larry C Wienkers; Robert S Foti
Journal:  Arch Biochem Biophys       Date:  2013-04-04       Impact factor: 4.013

3.  Extensive protein interactions involving cytochrome P450 3A4: a possible contributor to the formation of a metabolosome.

Authors:  Ryoichi Fujiwara; Tomoo Itoh
Journal:  Pharmacol Res Perspect       Date:  2014-07-02

Review 4.  Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.

Authors:  Ryoichi Fujiwara; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Front Pharmacol       Date:  2016-10-24       Impact factor: 5.810

5.  Endogenous Protein Interactome of Human UDP-Glucuronosyltransferases Exposed by Untargeted Proteomics.

Authors:  Michèle Rouleau; Yannick Audet-Delage; Sylvie Desjardins; Mélanie Rouleau; Camille Girard-Bock; Chantal Guillemette
Journal:  Front Pharmacol       Date:  2017-02-03       Impact factor: 5.810

6.  Exploring the Interactome of Cytochrome P450 2E1 in Human Liver Microsomes with Chemical Crosslinking Mass Spectrometry.

Authors:  Dmitri R Davydov; Bikash Dangi; Guihua Yue; Deepak S Ahire; Bhagwat Prasad; Victor G Zgoda
Journal:  Biomolecules       Date:  2022-01-22

7.  A strategy for enrichment of claudins based on their affinity to Clostridium perfringens enterotoxin.

Authors:  Dörte Lohrberg; Eberhard Krause; Michael Schümann; Jörg Piontek; Lars Winkler; Ingolf E Blasig; Reiner F Haseloff
Journal:  BMC Mol Biol       Date:  2009-06-22       Impact factor: 2.946

8.  UDP-Glucuronosyltransferase (UGT)-mediated attenuations of cytochrome P450 3A4 activity: UGT isoform-dependent mechanism of suppression.

Authors:  Yuu Miyauchi; Yoshitaka Tanaka; Kiyoshi Nagata; Yasushi Yamazoe; Peter I Mackenzie; Hideyuki Yamada; Yuji Ishii
Journal:  Br J Pharmacol       Date:  2020-01-23       Impact factor: 8.739

Review 9.  Revisiting the Latency of Uridine Diphosphate-Glucuronosyltransferases (UGTs)-How Does the Endoplasmic Reticulum Membrane Influence Their Function?

Authors:  Yuejian Liu; Michael W H Coughtrie
Journal:  Pharmaceutics       Date:  2017-08-30       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.